Partial atrophy in prostate needle biopsies: A detailed analysis of its morphology, immunophenotype, and cellular kinetics

American Journal of Surgical Pathology

Volumn 32, Issue 1, 2008, Pages 58-64

  Przybycin, Christopher G ^a   Kunju, Lakshmi P ^a   Wu, Angela J ^a   Shah, Rajal B ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Immunohistochemistry; Partial atrophy; Proliferative index; Prostate needle biopsy

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; CELL MARKER; KI 67 ANTIGEN;

ADULT; ARTICLE; ATROPHY; BASAL CELL; CELL KINETICS; CELL PROLIFERATION; CELL STRUCTURE; CHRONIC INFLAMMATION; CYTOPLASM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; MICRONUCLEUS; NEEDLE BIOPSY; NUCLEOLUS; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE DISEASE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STUDENT T TEST; UNITED STATES;

BIOPSY, NEEDLE; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; KI-67 ANTIGEN; MALE; PROSTATIC DISEASES; PROSTATIC NEOPLASMS; RACEMASES AND EPIMERASES;

EID: 37549044281     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318093e3f6     Document Type: Article

References (22)

1. Adley BP, Yang XJ. Alpha-methylacyl coenzyme A racemase immunoreactivity in partial atrophy of the prostate. Am J Clin Pathol. 2006;126:849-855.
2. Amin MB, Tamboli P, Varma M, et al. Postatrophic hyperplasia of the prostate gland: a detailed analysis of Its morphology in needle biopsy specimens. Am J Surg Pathol. 1999;23:925-931.
3. Baisden BL, Kahane H, Epstein J. Perineural invasion, mucinous fibroplasia, and glomerulations: diagnostic features of limited cancer on prostate needle biopsy. Am J Surg Pathol. 1999;23:918-924.
4. Billis A,Magna LA. Inflammatory atrophy of the prostate. Prevalence and significance. Arch Pathol Lab Med. 2003;127:840-844.
5. Bostwick DG, Srigley J, Grignon D, et al. Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma. Hum Pathol. 1993;24:819-832.
6. Das D, Shah RB, Imperiale MJ. Detection and expression of human BK virus sequences in neoplastic prostate tissues. Oncogene. 2004;23:7031-7046.
7. De Marzo AM, Marchi VL, Epstein JI, et al. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol. 1999;155:1985-1992.
8. De Marzo AM, Platz EA, Epstein JI, et al. A Working Group Classification of Focal Prostate Atrophy Lesions. Am J Surg Pathol. 2006;30:1281-1291.
9. Epstein J. Differential Diagnosis in Pathology: Urologic Disorders. New York: Igaku-Shoin; 1992:104-105.
10. Epstein J. Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy. Hum Pathol. 1995;26:223-229.
11. Herawi M, Parwani AV, Irie J, et al. Small glandular proliferations on needle biopsies: most common benign mimickers of prostatic adenocarcinoma sent in for expert second opinion. Am J Surg Pathol. 2005;29:874-880.
12. Jiang Z, Wu C-L, Woda BA, et al. P504S/alpha-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy. Am J Surg Pathol. 2002;26:1169-1174.
13. Kunju LP, Rubin MA, Chinnaiyan AM, et al. Diagnostic usefulness of monoclonal antibody P504S in the workup of atypical prostatic glandular proliferations. Am J Clin Pathol. 2003;120:737-745.
14. Kunju LP, Chinnaiyan AM, Shah RB. Comparison of monoclonal antibody (P504S) and polyclonal antibody to alpha methylacyl-CoA racemase (AMACR) in the work-up of prostate cancer. Histopathology. 2005;47:587-596.
15. Oppenheimer JR, Wills ML, Epstein JI. Partial atrophy in prostate needle cores: another diagnostic pitfall for the surgical pathologist. Am J Surg Pathol. 1998;22:440-445.
16. Ruska KM, Sauvageot JBS, Epstein JI. Histology and cellular kinetics of prostatic atrophy. Am J Surg Pathol. 1998;22:1073-1077.
17. Shah R, Mucci NR, Amin A, et al. Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander? Am J Pathol. 2001;158:1767-1773.
18. Shah RB, Zhou M, LeBlanc M, et al. Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer. Am J Surg Pathol. 2002;26:1161-1168.
19. Shah RB, Kunju LP, Shen R, et al. Usefulness of basal cell cocktail (34betaE12+p63) in the diagnosis of atypical prostate glandular proliferations. Am J Clin Pathol. 2004;122:517-523.
20. Shah RB, Mehra R, Chinnaiyan AM, et al. Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program. Cancer Res. 2004;64:9209-9216.
21. Srigley JR. Benign mimickers of prostatic adenocarcinoma. Mod Pathol. 2004;17:328-348.
22. Thorson P, Humphrey PA. Minimal adenocarcinoma in prostate needle biopsy tissue. Am J Clin Pathol. 2000;114:896-909.